Format

Send to

Choose Destination
Proc Am Thorac Soc. 2008 May 1;5(4):406-11. doi: 10.1513/pats.200707-095ET.

Cost-effectiveness of lung volume reduction surgery.

Author information

1
Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. sramsey@fhcrc.org

Abstract

Lung volume reduction surgery (LVRS) is a costly procedure that can improve quality and quantity of life. Given the prevalence of emphysema, the costs involved with its management, and resource constraints on all health care delivery systems, evaluating the cost-effectiveness of LVRS is important. In this article, we describe the purposes and principles of cost-effectiveness analysis and how those principles were applied in evaluating LVRS. We present the results of the cost-effectiveness analysis that was conducted alongside the National Emphysema Treatment Trial and other economic studies of LVRS and discuss how these should be interpreted in the context of current reimbursement guidelines.

PMID:
18453346
PMCID:
PMC2645310
DOI:
10.1513/pats.200707-095ET
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center